Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C and iron.

J K Olynyk1

  • 1Department of Medicine, Fremantle Hospital, University of Western Australia, Australia. jolynyk@cyllene.uwa.edu.au

The Keio Journal of Medicine
|October 27, 1999
PubMed
Summary
This summary is machine-generated.

Iron impacts Hepatitis C outcomes and treatment response. Targeting iron levels or cellular actions may improve therapies and clarify disease mechanisms for chronic viral hepatitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence.

Hepatology international·2023
Same author

Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort.

Human reproduction (Oxford, England)·2022
Same author

Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume.

Scandinavian journal of rheumatology·2020
Same author

Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age.

Human reproduction (Oxford, England)·2018
Same author

Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.

Molecular psychiatry·2016
Same author

Detection of liver injury in IBD using transient elastography.

Journal of Crohn's & colitis·2014
Same journal

Transcript of the Commemorative Lecture by Dr. Akiko Iwasaki (30th Keio Medical Science Prize Award Ceremony).

The Keio journal of medicine·2026
Same journal

Association of Loneliness and Health Literacy with Overuse of Over-the-counter Drugs in Patients with COVID-19 in Japan.

The Keio journal of medicine·2026
Same journal

Ligustilide Attenuates Neuroinflammation and Fibrosis in an Aluminum Chloride-induced Rat Model of Alzheimer's Disease via mTOR/STAT3 Signaling Inhibition.

The Keio journal of medicine·2026
Same journal

Community Pharmacists' Attitudes and Experiences Regarding the Promotion of Vaccinations in Japan.

The Keio journal of medicine·2026
Same journal

Identifying High-Cost RSV Hospitalizations at a Secondary Hospital in Japan.

The Keio journal of medicine·2026
Same journal

Comparison of Clinical Development of Digital Therapeutics among Japan, the Unites States, and Germany.

The Keio journal of medicine·2025
See all related articles

Area of Science:

  • Hepatology
  • Immunology
  • Viral Hepatitis Research

Background:

  • Hepatitis C is a leading cause of chronic liver disease, potentially leading to cirrhosis, liver failure, and liver cancer.
  • Interferon alpha has demonstrated efficacy in treating Hepatitis C, normalizing transaminase levels in many patients, though sustained responses are less common.
  • Emerging evidence indicates iron influences both the natural course and treatment responsiveness of chronic Hepatitis C.

Purpose of the Study:

  • To explore the role of iron in the pathogenesis and treatment of chronic Hepatitis C.
  • To investigate the potential of iron-modulating therapies for Hepatitis C.
  • To elucidate the cellular mechanisms by which iron affects Hepatitis C.

Main Methods:

  • Analysis of controlled trials on interferon alpha treatment for Hepatitis C.

Related Experiment Videos

  • Review of recent studies investigating the impact of iron on Hepatitis C.
  • Exploration of proposed mechanisms involving iron's cellular location and immune function.

    • Main Results:

    • Interferon alpha normalizes transaminases in up to 50% of Hepatitis C patients, with sustained responses in 15-25%.
    • Iron significantly influences the response to Hepatitis C treatment and the disease's progression.
    • The precise mechanisms of iron's influence are unclear, but cellular iron distribution and immune effects are implicated.

    Conclusions:

    • Iron's role in chronic Hepatitis C necessitates further investigation into its cellular mechanisms.
    • Therapies aimed at reducing iron or interfering with its cellular action show promise for Hepatitis C treatment.
    • Understanding iron's impact could reveal new insights into liver injury in Hepatitis C and inform novel therapeutic strategies.